← Back to Clinical Trials
Recruiting NCT06127628

Effectiveness of Ultrasound-guided Scalp Block for Supratentorial Craniotomy

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Pain, Postoperative
Sponsor University Malaysia Sarawak
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-04-01
Completion 2025-03
Interventions
Ultrasound-guided scalp block with ropivacaine 0.375%

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Pain management in patients undergoing neurosurgery is a very important issue. The effectiveness of USG-guided scalp blocks for pain management in craniotomy surgery is currently not known. The purpose of this clinical trial is to evaluate the effectiveness of ultrasound-guided scalp block when performed in patients who undergo supratentorial craniotomies.

Eligibility Criteria

Inclusion Criteria: * All American Society of Anesthesia class I to III patients undergoing elective supratentorial craniotomies under general anaesthesia. Exclusion Criteria: 1. Refusal to participate in the study 2. Contraindications to the performance of scalp block, such as local infections 3. Allergy to ropivacaine hydrochloride 4. Age \< 18 years old 5. Undergoing emergency craniotomies, posterior fossa surgery, or burr holes surgery 6. Pre-existing chronic pain (defined as persistent or recurrent pain lasting \> 3 months) 7. History of drug addiction (illicit substances and opioids use) or chronic alcohol abuse 8. Presence of uncontrolled systemic arterial hypertension, severe cardiovascular disease, severe kidney or severe liver diseases 9. Predicted to require postoperative ventilation in the intensive care unit 10. Psychiatric disorders, serious neurological diseases, or reduced consciousness GCS \< 14

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}